Ocular Therapeutix Inc’s recent filing unveils that its Officer SANJAY NAYAK acquired Company’s shares for reported $16273.0 on Nov 25 ’24. In the deal valued at $8.97 per share,1,814 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, PETER KAZUO KAISER bought 2,897 shares, generating $26,095 in total proceeds.
Before that, PRAVIN DUGEL bought 17,783 shares. Ocular Therapeutix Inc shares valued at $160,186 were divested by the Officer at a price of $9.01 per share.
Scotiabank initiated its Ocular Therapeutix Inc [OCUL] rating to a Sector outperform in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who increased its forecast for the stock in mid June from “a Hold” to “a Buy”. BofA Securities started covering the stock on February 09, 2024. It rated OCUL as “a Buy”.
Price Performance Review of OCUL
On Tuesday, Ocular Therapeutix Inc [NASDAQ:OCUL] saw its stock jump 7.26% to $9.75. Over the last five days, the stock has gained 9.30%. Ocular Therapeutix Inc shares have risen nearly 118.61% since the year began. Nevertheless, the stocks have risen 337.22% over the past one year. While a 52-week high of $11.77 was reached on 10/28/24, a 52-week low of $2.14 was recorded on 01/19/24. SMA at 50 days reached $9.92, while 200 days put it at $8.15.
Levels Of Support And Resistance For OCUL Stock
The 24-hour chart illustrates a support level at 9.24, which if violated will result in even more drops to 8.74. On the upside, there is a resistance level at 10.06. A further resistance level may holdings at 10.38. The Relative Strength Index (RSI) on the 14-day chart is 49.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.34%. Stochastics %K at 33.33% indicates the stock is a holding.
How much short interest is there in Ocular Therapeutix Inc?
A steep rise in short interest was recorded in Ocular Therapeutix Inc stocks on 2024-10-31, dropping by -3.52 million shares to a total of 12.67 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 16.19 million shares. There was a decline of -27.8%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 21, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
